Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
This short guide helps you decide which crypto to buy first by aligning choices with your goals, risk tolerance, and budget.
27,491 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
Gaotu's Q1 2026 earnings reveal clues about growth, profitability, and execution in a competitive online education ma...
MP Materials is catching investor attention again in 2026 as policy support, domestic production efforts, and a risin...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
This guide breaks down ameresco (amrc) 2025 earnings, what drives results, and how investors can position themselves ...
A new class action filed in California claims Kalshi misled traders in a Khamenei leadership prediction market, resul...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
A single message from Elon Musk can ripple through the stock market, nudging indices like Nasdaq and the S&P 500. Thi...
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...
Are you weighing a Roth IRA conversion? This guide highlights three signals that 2026 could perfect your move, plus a...